Literature DB >> 35976569

Tunneled catheter-related bacteremia in hemodialysis patients: incidence, risk factors and outcomes. A 14-year observational study.

Jesús Rodríguez-Baño1,2,3, Mercedes Salgueira-Lazo4,2,5, Marina Almenara-Tejederas6, María A Rodríguez-Pérez4, María J Moyano-Franco4, Marina de Cueto-López1.   

Abstract

BACKGROUND: Tunneled catheter-related bacteremia represents one of the major complications in patients on hemodialysis, and is associated with increased morbidity and mortality. This study aimed to evaluate the incidence of tunneled catheter-related bacteremia and, secondly, to identify possible factors involved in the first episode of bacteremia.
METHODS: This is a retrospective study of all tunneled catheters inserted between 1 January, 2005 and 31 December, 2019. Data on patients with a tunneled catheter were analyzed for comorbidities, catheter characteristics, microbiological culture results and variables related to the first episode of bacteremia. Patient outcomes were also assessed.
RESULTS: In the 14-year period under study, 406 tunneled catheters were implanted in 325 patients. A total of 85 cases of tunneled catheter-related bacteremia were diagnosed, resulting in an incidence of 0.40 per 1000 catheter days (81.1% after 6 months of implantation). The predominant microorganisms isolated were Gram-positive organisms: Staphylococcus epidermidis (48.4%); Staphylococcus aureus (28.0%). We found no significant differences in time to catheter removal for infections or non-infection-related reasons. The jugular vein, the Palindrome® catheter, and being the first vascular access were protective factors for the first episode of bacteremia. The 30-day mortality rate from the first tunneled catheter-related bacteremia was 8.7%.
CONCLUSIONS: The incidence of bacteremia in our study was low and did not seem to have a relevant impact on catheter survival. S. epidermidis was the most frequently isolated microorganism, followed by S. aureus. We identified Palindrome® catheter, jugular vein, and being the first vascular access as significant protective factors against tunneled catheter-related bacteremia.
© 2022. The Author(s).

Entities:  

Keywords:  Bacteremia; Bloodstream; Hemodialysis; Tunneled catheter

Year:  2022        PMID: 35976569     DOI: 10.1007/s40620-022-01408-8

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   4.393


  1 in total

1.  Spanish Clinical Guidelines on Vascular Access for Haemodialysis.

Authors:  José Ibeas; Ramon Roca-Tey; Joaquín Vallespín; Teresa Moreno; Guillermo Moñux; Anna Martí-Monrós; José Luis Del Pozo; Enrique Gruss; Manel Ramírez de Arellano; Néstor Fontseré; María Dolores Arenas; José Luis Merino; José García-Revillo; Pilar Caro; Cristina López-Espada; Antonio Giménez-Gaibar; Milagros Fernández-Lucas; Pablo Valdés; Fidel Fernández-Quesada; Natalia de la Fuente; David Hernán; Patricia Arribas; María Dolores Sánchez de la Nieta; María Teresa Martínez; Ángel Barba
Journal:  Nefrologia       Date:  2017-11       Impact factor: 2.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.